Banque Transatlantique’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85M Buy
4,400
+184
+4% +$103K 0.06% 97
2026
Q1
$2.37M Sell
4,216
-214
-5% -$137K 0.06% 93
2025
Q4
$3M Sell
4,430
-55
-1% -$37.5K 0.07% 61
2025
Q3
$2.86M Sell
4,485
-608
-12% -$369K 0.07% 62
2025
Q2
$2.75M Sell
5,093
-104
-2% -$49.7K 0.08% 55
2025
Q1
$2.18M Sell
5,197
-1,294
-20% -$562K 0.07% 61
2024
Q4
$2.68M Buy
+6,491
New +$2.85M 0.07% 57

Other funds holding IDXX

Banque Transatlantique's IDXX Position: Q2 2026 in Review

Banque Transatlantique increased its Idexx Laboratories (IDXX) stake by 4.4% in Q2 2026, buying an estimated $103K and bringing the position to 4,400 shares worth $2.85M. The position accounts for 0.06% of the portfolio, ranked #97.

Banque Transatlantique first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $3M in Q4 2025. 715 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Banque Transatlantique held 4,400 shares of Idexx Laboratories worth $2.85M as of Q2 2026.
  • Banque Transatlantique bought 184 Idexx Laboratories shares in Q2 2026, an estimated $103K.
  • Idexx Laboratories made up 0.06% of Banque Transatlantique's portfolio in Q2 2026, its #97 holding.
  • Banque Transatlantique first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Banque Transatlantique's Idexx Laboratories position peaked at $3M in Q4 2025.
  • 715 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Banque Transatlantique's 13F filing for Q2 2026, filed 30 Jul 2026.